Addition of plasma exchange to glucocorticosteroids for the treatment of severe Henoch-Schönlein purpura in adults: A case series

American Journal of Kidney Diseases

Volumn 59, Issue 5, 2012, Pages 663-669

  Augusto, Jean François ^a,b   Sayegh, Johnny ^a   Delapierre, Laurence ^c   Croue, Anne ^a   Tollis, Fréderic ^d   Cousin, Maud ^a   Subra, Jean François ^a,b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c Avignon Hospital   (France)

^d Diaverum Dialysis Center   (France)

Author keywords

Adult; Henoch Sch nlein purpura; nephritis; plasma exchange; steroids

Indexed keywords

ACID CITRATE DEXTROSE; INSULIN; METHYLPREDNISOLONE; PREDNISONE;

ADULT; AGED; ANAPHYLACTOID PURPURA; ARTICLE; BIRMINGHAM VASCULITIS ACTIVITY SCORE; CASE STUDY; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; DIABETES MELLITUS; DIALYSIS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; MALE; MEDICAL ASSESSMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PLASMAPHERESIS; PREGNANCY; PROTEINURIA; SEPTICEMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PLASMA EXCHANGE; PROTEINURIA; PURPURA, SCHOENLEIN-HENOCH; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859805847     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.12.015     Document Type: Article

References (28)

1. McCarthy HJ, Tizard EJ. Clinical practice: diagnosis and management of Henoch-Schönlein purpura. Eur J Pediatr. 2009;169:643-650.
2. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schönlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol. 2002;13:1271-1278. (Pubitemid 34441408)
3. Fogazzi GB, Pasquali S, Moriggi M, et al. Long-term outcome of Schönlein-Henoch nephritis in the adult. Clin Nephrol. 1989;31:60-66. (Pubitemid 19061038)
4. Davin JC. Henoch-Schönlein purpura nephritis: pathophysiology, treatment, and future strategy. Clin J Am Soc Nephrol. 2011;6:679-689.
5. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187-192. (Pubitemid 24065492)
6. Pillebout E, Alberti C, Guillevin L, Ouslimani A, Thervet E. Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein purpura. Kidney Int. 2010;78:495-502.
7. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. Amore accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461-470. (Pubitemid 29135798)
8. Luqmani RA, Bacon PA, Moots RJ, et al. Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis. QJM. 1994;87:671-678. (Pubitemid 24334817)
9. Bussel A, Jais JP. Side effects and mortality associated with plasma exchange: a three year experience with a regional register. Life Support Syst. 1987;5:353-358.
10. Jayne DR, Gaskin G, Rasmussen N, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007;18:2180-2188. (Pubitemid 47041083)
11. Yang YH, Chuang YH, Wang LC, Huang HY, Gershwin ME, Chiang BL. The immunobiology of Henoch-Schönlein purpura. Autoimmun Rev. 2008;7:179-184.
12. Coppo R, Basolo B, Roccatello D, et al. Plasma exchange in progressive primary IgAnephropathy. Int J Artif Organs. 1985;8:55-58. (Pubitemid 16209366)
13. Bogdanovic R. Henoch-Schönlein purpura nephritis in children: risk factors, prevention and treatment. Acta Paediatr. 2009;98:1882-1889.
14. Niaudet P, Habib R. Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis. Pediatr Nephrol. 1998;12:238-243. (Pubitemid 28204133)
15. Andersen RF, Rubak S, Jespersen B, Rittig S. Early high-dose immunosuppression in Henoch-Schönlein nephrotic syndrome may improve outcome. Scand J Urol Nephrol. 2009;43:409-415.
16. Flynn JT, Smoyer WE, Bunchman TE, Kershaw DB, Sedman AB. Treatment of Henoch-Schönlein purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide. Am J Nephrol. 2001;21:128-133. (Pubitemid 32453691)
17. Kawasaki Y, Suyama K, Hashimoto K, Hosoya M. Methylprednisolone pulse plus mizoribine in children with Henoch- Schönlein purpura nephritis. Clin Rheumatol. 2011;30:529-535.
18. Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N. Multiple combined therapy for severe Henoch-Schonlein nephritis in children. Pediatr Nephrol. 1998;12:244-248. (Pubitemid 28204134)
19. Gaskell H, Searle M, Dathan JR. Henoch-Schönlein purpura with severe ileal involvement responding to plasmapheresis. Int J Artif Organs. 1985;8:163-164. (Pubitemid 15047776)
20. Chen TC, Chung FR, Lee CH, Huang SC, Chen JB, Hsu KT. Successful treatment of crescentic glomerulonephritis associated with adult-onset Henoch-Schönlein purpura by double-filtration plasmapheresis. Clin Nephrol. 2004;61:213-216. (Pubitemid 38396913)
21. Rech J, Fuchs F, Kallert S, et al. Plasmapheresis therapy in an elderly patient with rapidly progressive Henoch-Schönlein purpura with disseminated organ involvement. Clin Rheumatol. 2007;26:112-114. (Pubitemid 46020037)
22. Lee J, Clayton F, Shihab F, Goldfarb-Rumyantzev A. Successful treatment of recurrent Henoch-Schönlein purpura in a renal allograft with plasmapheresis. Am J Transplant. 2008;8:228-231.
23. Donghi D, Schanz U, Sahrbacher U, et al. Life-threatening or organ-impairing Henoch-Schönlein purpura: plasmapheresis may save lives and limit organ damage. Dermatology. 2009;219:167-170.
24. Hattori M, Ito K, Konomoto T, Kawaguchi H, Yoshioka T, Khono M. Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schönlein purpura nephritis in children. Am J Kidney Dis. 1999;33:427-433. (Pubitemid 29107018)
25. Kawasaki Y, Suzuki J, Murai M, et al. Plasmapheresis therapy for rapidly progressive Henoch-Schönlein nephritis. Pediatr Nephrol. 2004;19:920-923. (Pubitemid 39144779)
26. Shenoy M, Ognjanovic MV, Coulthard MG. Treating severe Henoch-Schönlein and IgA nephritis with plasmapheresis alone. Pediatr Nephrol. 2007;22:1167-1171.
27. Hass M. IgA nephropathy and Henoch-Schönlein purpura. In: Jeannette JC, ed. Heptinstall's Pathology of the Kidney. 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2006:423-486.
28. Ou ZL, Nakayama K, Natori Y, Doi N, Saito T. Effective methylprednisolone dose in experimental crescentic glomerulonephritis. Am J Kidney Dis. 2001;37:411-417. (Pubitemid 32116035)